Opendata, web and dolomites

bECOMiNG SIGNED

spontaneous Evolution and Clonal heterOgeneity in MoNoclonal Gammopathies: from mechanisms of progression to clinical management

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 bECOMiNG project word cloud

Explore the words cloud of the bECOMiNG project. It provides you a very rough idea of what is the project "bECOMiNG" about.

candidate    gammopathy    invasive    progression    cancer    paradigm    precision    detected    clinical    time    alterations    multiple    individuals    determinants    serial    rationale    mm    hip    identification    screens    blood    heterogeneity    evolution    look    stage    preceded    analyze    dna    screening    cells    collect    trajectory    genomics    follow    predict    conventional    replacement    vulnerabilities    course    sampling    hypothesis    frequency    clonal    elderly    expertise    lesions    marrow    biological    prognostic    mini    contributed    peripheral    innovative    hematologist    annotated    therapies    functionally    significantly    scores    genotypic    samples    sharp    free    molecularly    evolutionary    outcome    markers    permissive    phenotypic    monoclonal    genotyping    onco    single    subpopulations    specimens    serve    bm    archive    mms    circulating    prevalent    retrospective    preliminary    myeloma    thousands    disease    microenvironment    cohorts    initiation    stages    prediction    cell    correlation    prospective    phenotyping    accurately    hundreds    dissect    last    healthy    aggressive    genomic    list    bone    medicine    biomarkers    modifier    exploited    as    evolve    asymptomatic    captured    move    data   

Project "bECOMiNG" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI MILANO 

Organization address
address: Via Festa Del Perdono 7
city: MILANO
postcode: 20122
website: www.unimi.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 1˙998˙781 €
 EC max contribution 1˙998˙781 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-COG
 Funding Scheme ERC-COG
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2024-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI MILANO IT (MILANO) coordinator 1˙998˙781.00

Map

 Project objective

As an onco-hematologist with a strong expertise in genomics, I significantly contributed to the understanding of multiple myeloma (MM) heterogeneity and its evolution over time, driven by genotypic and phenotypic features carried by different subpopulations of cells. MM is preceded by prevalent, asymptomatic stages that may evolve with variable frequency, not accurately captured by current clinical prognostic scores. Supported by preliminary data, my hypothesis is that the same heterogeneity is present early on the disease course, and identification of the biological determinants of evolution at this stage will allow better prediction of its evolutionary trajectory, if not its control. In this proposal I will therefore make a sharp change from conventional approaches and move to early stages of MM using unique retrospective sample cohorts and ambitious prospective sampling. To identify clonal MM cells in the elderly before a monoclonal gammopathy can be detected, I will collect bone marrow (BM) from hundreds of hip replacement specimens, and analyze archive peripheral blood samples of thousands of healthy individuals with years of annotated clinical follow-up. This will identify early genomic alterations that are permissive to disease initiation/evolution and may serve as biomarkers for clinical screening. Through innovative, integrated single-cell genotyping and phenotyping of hundreds of asymptomatic MMs, I will functionally dissect heterogeneity and characterize the BM microenvironment to look for determinants of disease progression. Correlation with clinical outcome and mini-invasive serial sampling of circulating cell-free DNA will identify candidate biological markers to better predict evolution. Last, aggressive modelling of candidate early lesions and modifier screens will offer a list of vulnerabilities that could be exploited for rationale therapies. These methodologies will deliver a paradigm for the use of molecularly-driven precision medicine in cancer.

 Publications

year authors and title journal last update
List of publications.
2019 Maura, Francesco; Degasperi, Andrea; Nadeu, Ferran; Leongamornlert, Daniel; Davies, Helen; Moore, Luiza; Royo, Romina; Ziccheddu, Bachisio; Puente, Xose S.; Avet-Loiseau, Herve; Cambell, Peter J.; Nik-Zainal, Nik; Campo, Elias; Munshi, Nikhil; Bolli, Niccolò
A practical guide for mutational signature analysis in hematological malignancies
published pages: , ISSN: 2041-1723, DOI: 10.17863/CAM.41719
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019) 1 2020-03-05
2019 Francesco Maura, Niccoló Bolli, Nicos Angelopoulos, Kevin J. Dawson, Daniel Leongamornlert, Inigo Martincorena, Thomas J. Mitchell, Anthony Fullam, Santiago Gonzalez, Raphael Szalat, Federico Abascal, Bernardo Rodriguez-Martin, Mehmet Kemal Samur, Dominik Glodzik, Marco Roncador, Mariateresa Fulciniti, Yu Tzu Tai, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Paolo Corradini, Kenneth
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-11680-1
Nature Communications 10/1 2020-03-05

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BECOMING" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BECOMING" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

OSIRIS (2020)

Automatic measurement of speech understanding using EEG

Read More  

ORGANITRA (2019)

Transport of phosphorylated compounds across lipid bilayers by supramolecular receptors

Read More  

HyperBio (2019)

Vis-NIR Hyperspectral imaging for biomaterial quality control

Read More